Cargando…
Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum
Autores principales: | Liu, Haoran, Yang, Xiaoqi, Tang, Kun, Ye, Tao, Duan, Chen, Lv, Peng, Yan, Libin, Wu, Xiaoliang, Chen, Zhiqiang, Liu, Jianhe, Deng, Yaoliang, Zeng, Guohua, Xing, Jinchun, Ye, Zhangqun, Xu, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690918/ https://www.ncbi.nlm.nih.gov/pubmed/34987656 http://dx.doi.org/10.7150/thno.68830 |
Ejemplares similares
-
Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis
por: Liu, Haoran, et al.
Publicado: (2020) -
XIST Inhibition Attenuates Calcium Oxalate Nephrocalcinosis-Induced Renal Inflammation and Oxidative Injury via the miR-223/NLRP3 Pathway
por: Lv, Peng, et al.
Publicado: (2021) -
AhR activation attenuates calcium oxalate nephrocalcinosis by diminishing M1 macrophage polarization and promoting M2 macrophage polarization
por: Yang, Xiaoqi, et al.
Publicado: (2020) -
H19 promote calcium oxalate nephrocalcinosis-induced renal tubular epithelial cell injury via a ceRNA pathway
por: Liu, Haoran, et al.
Publicado: (2019) -
Metformin suppresses calcium oxalate crystal-induced kidney injury by promoting Sirt1 and M2 macrophage-mediated anti-inflammatory activation
por: Liu, Haoran, et al.
Publicado: (2023)